| Literature DB >> 29933405 |
R B Giesberts1, M C van der Steen2, P G M Maathuis3, A T Besselaar2,4, E E G Hekman1, G J Verkerke1,5.
Abstract
BACKGROUND: Clubfeet are commonly treated using the Ponseti method. This method involves weekly manipulation and casting which gradually corrects the position of the foot. However, the reasons for following a weekly interval are not clear. QUESTION /Entities:
Mesh:
Year: 2018 PMID: 29933405 PMCID: PMC6014642 DOI: 10.1371/journal.pone.0199540
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Levels of evidence.
| Level | Description |
|---|---|
| Strong evidence | Two or more studies with low risk of bias and by generally consistent findings in all studies (≥75% of the studies reported consistent findings) |
| Moderate evidence | One low risk of bias study and two or more high risk of bias studies and by generally consistent findings in all studies (≥75%) |
| Limited evidence | One or more high risk of bias studies or one low risk of bias study and by generally consistent findings (≥75%) |
| Conflicting evidence | Conflicting findings (<75% of the studies reported consistent findings) |
| No evidence | No studies could be found |
Fig 1PRISMA flow diagram.
Process of study identification and selection for outcome analysis [8].
Study characteristics.
| Study | Study design | Group | Nr of Subjects | Nr of Clubfeet | Age at onset (months) | Prior treatment (%) | Pre-treatment Pirani score | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|
| Prospective randomized | N | 20 | 34 | 2.5 | 11.8 | 5.17 | 25.25 | |
| A | 21 | 32 | 2.7 | 15.6 | 5.13 | 23.38 | ||
| Prospective randomized | N | 40 | 61 | 5.09 | 0 | 4.12 | - | |
| A | 40 | 62 | 4.57 | 4.35 | ||||
| Prospective randomized | N | 21 | 32 | 1.0 | - | 5.0 | 8.0 | |
| A | 19 | 29 | 0.7 | 5.5 | 8.5 | |||
| Prospective randomized | N | 14 | 23 | 1.1 | 0 | 5 | - | |
| A | 14 | 22 | 1.9 | 4.8 | - | |||
| Prospective randomized | N | 20 | 26 | 0.93 | - | 4.97 | 3 or 6 | |
| A | 20 | 25 | 0.92 | 5.025 | 3 or 6 | |||
| Retrospective | N | 111 | 162 | 5 | 72 | - | - | |
| A | 108 | 157 | 3 | |||||
| Prospective randomized | N | 27 | 40 | 1.3 | 0 | 5.03 | 11 | |
| A | 26 | 40 | 1.21 | 5.3 | ||||
| Prospective randomized | N | 20 | 26 | 0.75 | 0 | 5.32 | 7.7 | |
| A | 20 | 27 | 0.77 | 5.21 | 8.2 | |||
| N | 20 | 32 | 2.10 | - | 4.0 | 48 | ||
| A | 26 | 40 | 3.09 | 4.1 |
N = Normal group, A = Accelerated group. Unless indicated otherwise, data is presented as it is in the selected paper, as means. Not reported data is indicated with ‘-’.
a presented as median
b patients with any form of prior treatment were excluded
c for both groups combined
d calculated over presented data
e personal communication
Risk of bias analysis.
| Study | 1—Randomization of groups | 2—Comparability of groups | 3—Follow-up sufficiency | 4—Definition of outcomes | 5—Documentation of outcomes | 6—Blinded assessment of outcomes | 7—Blinded participants and personnel | Risk of bias |
|---|---|---|---|---|---|---|---|---|
| + | + | ? | + | + | ? | - | Low | |
| + | ? | - | - | - | ? | - | High | |
| + | + | ? | + | + | ? | - | Low | |
| + | + | - | + | ? | - | - | High | |
| + | + | - | ? | + | ? | - | High | |
| - | - | ? | + | - | ? | - | High | |
| + | + | - | + | ? | ? | - | High | |
| + | + | - | + | + | ? | - | Low | |
| - | ? | + | + | + | ? | - | High |
‘+’ was given if the used methodology was clear and adequate, and all required data was present
‘?’ was given if the used methodology was unclear or statistical information was missing
‘-’ was given if the used methodology was faulty or data was missing or not presented per subgroup
Note that in order to be classified as low risk of bias, items 1, 2, 4 and 5 needed to be positively scored
Extracted data from the selected papers.
| Study | Group | Interval | Average nr of casts | Duration | Complications | Tenotomy rate | Failure rate | Surgery | Relapse |
|---|---|---|---|---|---|---|---|---|---|
| N | 7 | 4.88 | 0 | 91.2 | 0 | 3 (9%) | 5 (15%) | ||
| (2015) | A | 3.5 | 5.16 | 93.8 | 0 | 3(9%) | 5 (16%) | ||
| N | 7 | 5.2 | - | 71.2 | 2 (5%) | 2 (5%) | - | ||
| (2014) | A | 3.5 | 5.12 | 4 (10%) | 4 (10%) | ||||
| N | 7 | 5 | 0 | 52 | 2 (10%) | 2 (10%) | 0 | ||
| (2011) | A | 2.3 | 5 | 79 | 3 (16%) | 1 (5%) | |||
| N | 7 | 5.26 | 52 | - | 96 | 0 | - | - | |
| (2017) | A | 3.5 | 6.23 | 39 | 100 | 0 | |||
| N | 7 | 5.55 | 52.8 | 0 | 11.5 | - | 0 | 3 (15%) | |
| (2016) | A | 3.5 | 5.95 | 39.65 | 24 | 1 (5%) | 4 (20%) | ||
| N | 7 | 4 | - | 81 | - | 21 (10%) | |||
| (2005) | A | 5 | 85 | ||||||
| N | 7 | 6.2 | - | 78 | - | 0 | 9 (23%) | ||
| (2015) | A | 3 | 7.4 | 83 | 1 (4%) | 13 (33%) | |||
| N | 7 | 5.08 | 0 | 77 | 1 (5%) | 1 (5%) | 0 | ||
| (2016) | A | 3.5 | 4.15 | 74 | 1 (5%) | 1 (5%) | |||
| N | 7 | 5.25 | 0 | 87.5 | 5 (16%) | 4 (13%) | - | ||
| (2011) | A | 3.5 | 5.04 | 87.5 | 6 (15%) | 6 (15%) |
N = Normal group, A = Accelerated group. Unless indicated otherwise, data is presented as it is in the selected paper. Not reported data is indicated with ‘-’. Numbers in bold represent a statistical significant difference (p < 0.05).
a presented as median
b for both groups combined
c including tenotomy cast
d calculated from casts × interval, not included in the best evidence synthesis
e three subjects crossed-over to the control group because they still had Pirani > 1.0 after 21 days
Best evidence synthesis of outcome measures.
| Nr of studies | Statistically significant difference | No statistically significant difference | Best evidence synthesis | Comments | |
|---|---|---|---|---|---|
| 7 | LR: 0 | LR: 3 | Strong evidence no relation | Statistical significance not reported in Sahu, Rajavelu (18). Mean 6.2 (range 4–10) vs 7.4 (5–10) casts: inconclusive | |
| 8 | LR: 0 | LR: 3 | Strong evidence no relation | ||
| 6 | LR: 3 | LR: 0 | Strong evidence positive relation | Statistical significance not reported in Sahu, Rajavelu (18). Mean 57.4 vs 23.8 days: inconclusive | |
| 7 | LR: 0 | LR: 3 | Strong evidence no relation | Morcuende, Abbasi (9) surgery data for both groups combined: inconclusive | |
| 4 | LR: 0 | LR: 1 | Moderate evidence no relation | ||
| 5 | LR: 0 | LR: 3 | Strong evidence no relation | No statistical test in Elgohary and Abulsaad (15). No difference in post-treatment Pirani score (reported p = 0.89), all scores were ≤ 1.0: assumed as no statistical significant difference. |
LR = Low Risk of bias, HR = High Risk of bias
“Significant difference” indicates the number of selected studies in which a statistically significant difference was found.